INDIANAPOLIS, Dec. 20 /PRNewswire/ -- Testing blood sugar levels is one of
the most important things that people with diabetes can do to help manage
their disease and live a healthy lifestyle. However, an Omnibus survey of
1,002 adults with type 1 and type 2 diabetes indicates that almost 4 out of 10
do not test as often as their doctors recommend. Respondents cited having to
reprick (48%) and painful testing (43%) as the most commonly encountered
problems while testing blood glucose levels.(1)
Based on these national survey results, people with diabetes may consider
a New Year's commitment to better managing their diabetes by testing their
blood glucose levels more often in order to stay healthy. For example, the
ACCU-CHEK Aviva system is a blood glucose management tool that addresses their
needs and can help them be healthy in the New Year. It helps alleviate
repricking and eases painful testing.
"There is no substitute for blood sugar monitoring. Testing is the best
measure by which we can accurately determine the adequacy of our patients'
blood sugar control," said Dr. Henry Rodriguez, Assistant Professor of
Pediatrics, Indiana University School of Medicine, and Director of the
Pediatric Diabetes Clinical Program, James Whitcomb Riley Hospital for
Children. "Products that can help increase testing frequency by taking away
their frustrations are very important. It can help people with diabetes live
a healthier lifestyle and greatly enhance their ability to improve management
of their diabetes."
According to the Omnibus survey, respondents listed the top five barriers
1. Having to reprick
2. Painful testing
3. Wondering if the test result is really accurate
4. Difficulty drawing a large enough sample of blood
5. Having to retest due to an error message
The ACCU-CHEK Aviva system helps to address each of these needs. A wide
mouth on the test strip quickly pulls in the small blood sample (0.6
microliter) and is designed to fill the very first time. The test strips are
larger and wider than other leading systems, making them easier to handle for
patients of all ages.
Another finding from the Omnibus survey was that 95% of respondents
indicated they would switch brands if they could find a meter system that
would reduce the pain of testing(1) (painful testing was listed as the second
of the top five barriers to testing). In addition to helping avoid painful
repricking due to unsuccessful tests or error messages, the system also
includes the ACCU-CHEK Multiclix lancet device, which has a preloaded six-
lancet drum, a patented cam-driven design, 11 different depth settings and
supports alternate site testing. The ACCU-CHEK Multiclix lancet device has
been proven the least painful lancing option(2) and eliminates the need for
patients to see or handle individual lancets.
"People with diabetes need products that meet their specific needs and
ensure confidence," said Don Dumoulin, Senior Vice President, U.S. Diabetes
Care, Roche Diagnostics. "Through our research, we've found that the hassle
and pain of retesting are barriers to people testing as often as they should.
The ACCU-CHEK Aviva system and ACCU-CHEK Multiclix lancet device are solutions
to their concerns and help them test right the first time. During this time
of year, people often make New Year's pledges about their health, and this is
a great product to help people test as they should."
The Omnibus national survey also shows that patients have a desire to have
integrated solutions that help them collect, analyze and act to help them
manage their diabetes more easily, including:
* More than four in ten said they would be much more likely to buy a
company's products if the company offered meters, pumps and other products
that work together to help manage diabetes (46%) and if it provided tools that
make it easier to share test results with their doctors (45%)(1).
* More than half of insulin users (and 62% of those who test four or more
times a day) said they would be much more likely to buy a company's products
if the company offered products and services to help them collect relevant
information, analyze and act on it all for better self-management of
The ACCU-CHEK Aviva blood glucose system was developed in response to
extensive market research in the United States and Europe. As a result, it
provides users with features most important to them and helps them test right
the first time, allowing them to avoid the pain of retesting. During
research, 97% of consumers dosed the ACCU-CHEK Aviva test strip successfully
on the first attempt.(3) In a consumer study, the ACCU-CHEK Multiclix lancet
device was shown to be less painful, easier to use and quicker than the
leading competitive lancing systems.(2)
A total of 1,002 insulin users completed the Omnibus survey July 14-19,
2005. The sample, selected from Synovate's online Consumer Opinion Panel, was
drawn from 3,400 households. Results for the total sample are accurate to
within plus or minus 3%.
For more information please contact:
(1) Synovate's online Consumer Opinion Panel, "Barriers to Blood Glucose
Testing". Data on file.
(2) Koubek, R.J., "Glucose Monitoring System Design Reduces Barriers to
Testing," ACCU-CHEK Aviva system and ACCU-CHEK Multiclix lancet device human
factors white paper, 2005.
(3) ACCU-CHEK Aviva Evaluation Report. Data on file.
ACCU-CHEK, ACCU-CHEK AVIVA, ACCU-CHEK MULTICLIX, ACCU-CHEK COMPACT,
SOFTCLIX and ACCU-CHEK COMPASS are trademarks of Roche.
SOURCE Roche Diagnostics